VIPR1 and cancer: An in vitro study of >400 human primary tumors, tumor metastases, and normal tissues using subtype selective VPAC receptor autoradiography has established that most cancers express VPAC, with VPAC1 being the predominant receptor subtype in cancers and healthy tissues [11].